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Among 397 homeless participants studied, the overall 
West Nile virus (WNV) seroprevalence was 6.8%. Risk factors 
for WNV infection included being homeless >1 year, spend-
ing >6 hours outside daily, regularly taking mosquito precau-
tions, and current marijuana use. Public health interventions 
need to be directed toward this high-risk population.
W
est Nile virus (WNV) was ﬁ  rst identiﬁ  ed in Houston 
in 2002 (1). From 2002 through 2004, 6% of patients 
hospitalized with WNV infection were homeless (2), which 
raised concerns that the homeless population might be at 
increased risk for infection. This study was conducted to 
determine the seroprevalence of WNV in Houston’s home-
less population after 2 transmission seasons and to deter-
mine risk factors for infection.
The Study
A cross-sectional survey was conducted by using con-
venience sampling of homeless shelters, soup kitchens, 
homeless camps, and mobile outreach organizations. Par-
ticipants gave consent and were assigned a unique study 
number to preserve anonymity. An interviewer-adminis-
tered questionnaire collected information on demograph-
ics, social and medical histories, housing status during 
the 2002 and 2003 WNV transmission seasons, length of 
time homeless, and outdoor exposures. The study was ap-
proved by the University of Texas Health Science Center at 
Houston Committee for the Protection of Human Subjects 
(HSC-SPH-03-111). 
 A Mini–Mental State Examination (MMSE) was per-
formed to evaluate the cognitive status of the participant. 
Participants who scored <75% on the MMSE were con-
sidered cognitively impaired, and therefore their interview 
responses were excluded.
As incentive, participants were provided free onsite 
testing and counseling for HIV, hepatitis B, hepatitis C, 
and WNV infections. Blood samples were collected and 
later tested for WNV antibodies by immunoglobulin G 
(IgG) ELISA and hemagglutination inhibition (HI) test. 
Samples were considered WNV antibody–positive if both 
the IgG ELISA and HI assay gave positive reactions. Data 
were entered into a Microsoft (Redmond, WA, USA) Ac-
cess database and analyzed by using Stata 8.0 (Stata Corp., 
College Station, TX, USA). WNV prevalence and risk of 
becoming infected were calculated for each variable. Uni-
variate odds ratios (ORs) with  p<0.25 were included in a 
logistic regression model. A backward stepwise approach 
was used to eliminate variables with p>0.10 to determine a 
ﬁ  nal model. Interactions between variables were assessed 
for signiﬁ   cance (p<0.10), and the Hosmer-Lemeshow 
goodness-of-ﬁ  t statistic (3) was used to evaluate the ﬁ  t of 
the ﬁ  nal model.
During the spring of 2004, 424 participants were en-
rolled from 13 sites; 8 were excluded due to low MMSE 
scores. Of the 416 participants, 397 had complete inter-
views, adequate blood samples, and were included in the 
analysis. This sampling represents ≈4% of Houston’s esti-
mated 10,000 homeless population (4).
Of the 397 participants, 27 were WNV positive (sero-
prevalence 6.8%; 95% conﬁ  dence interval [CI] 4.5–9.7). 
Men represented 72% of the participants, with 8.4% found 
to be positive for WNV, compared with 2.7% of women 
(OR 3.3; 95% CI 0.96–11.0) (Table 1). The study popula-
tion was 59% black, 30% white, and 11% “other” or not 
stated; 13% were of Hispanic ethnicity. Mean age was 42 
years (range 18–69 years).
For both 2002 and 2003 transmission seasons, 278 
(70%) participants reported having stable housing, and 
WNV seroprevalence was 4.7% (95% CI 2.5–7.9) (Table 
2). For those who had unstable housing in both 2002 and 
2003 (n = 45; 11%), we found a signiﬁ  cantly higher WNV 
seroprevalence of 13.3% (OR 3.1, 95% CI 1.1–8.7). For 
those who reported being homeless >1 year (n = 73; 18%), 
seroprevalence for WNV was 16.4% (95% CI 8.8–27.0), 
with a signiﬁ  cantly increased risk for WNV infection when 
compared with those who did not consider themselves 
homeless or were homeless <1 month (OR 3.2; 95% CI 
1.3–7.7, p = 0.01). When asked about the average length 
of time spent outdoors during the summer and fall, 38% 
reported <6 hours per day (seroprevalence 2.0%), 38% 
reported >6–12 hours (seroprevalence 8.0%), and 24% 
reported >12 hours (seroprevalence 12.5%). There was a 
positive trend (p value for trend 0.002) between number of 
hours spent outside and increased risk for WNV infection. 
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Current marijuana use was also associated with WNV in-
fection (OR 2.5; 95% CI 1.0–6.0).
Univariate analysis identiﬁ  ed the following variables 
as signiﬁ  cantly (α<0.05) associated with risk for WNV in-
fection: unstable housing in 2002 and 2003, being home-
less >1 year, spending >6 hours outside per day during 
the summer and fall, and current marijuana use. The ﬁ  nal 
logistic regression model identiﬁ  ed the following inde-
pendent risk factors (p<0.10) for WNV infection: being 
homeless >1 year (OR 3.8, p = 0.002), spending >6 hours 
outdoors (OR 4.3, p = 0.02), normally taking mosquito 
precautions (OR 2.8, p = 0.04), and current marijuana use 
(OR 2.4, p = 0.07). The Hosmer-Lemeshow goodness-of-
ﬁ  t-test statistic was 12.4 (p>0.19), which suggests that the 
model is a good ﬁ  t. When interaction terms were entered 
into the model, the interaction between marijuana smok-
ing and spending >6 hours outdoors was signiﬁ  cant (like-
lihood ratio p = 0.04) and increased the strength of the 
association with WNV infection.
Conclusions 
We believe this is the ﬁ  rst study to determine the prev-
alence of WNV in homeless adults and to determine risk 
factors for becoming infected among this high-risk urban 
population. Findings from this study will help public health 
authorities determine appropriate intervention and preven-
tion strategies.
We found a seroprevalence of 6.8% in our sample of 
homeless persons, with a seroprevalence of 16.4% in per-
sons reporting being homeless >1 year. Other studies have 
assessed the prevalence of WNV in general populations in 
the United States (5–10), with estimates of 0%–14%. 
To our knowledge, this is the ﬁ  rst report of WNV serop-
revalence in a population with high-risk outdoor exposures. 
Only 3 studies have evaluated risk factors for infection in 
the United States and found that increased time outdoors 
(5,8), inconsistent use of mosquito repellant (5), and age 
(9) were predictors for infection. In Houston’s homeless 
population, spending >6 hours outside per day during the 
summer and fall and being homeless >1 year independently 
predicted risk for infection. Although being homeless >1 
year was highly associated with increased time spent out-
doors, this variable also independently predicted infection. 
This ﬁ  nding is important in a public health context because 
it highlights a strong potential for further cases of WNV 
infection in this population.
We found that regularly using mosquito precautions 
was associated with an increased risk for infection, which 
differs from the ﬁ  ndings in New York (5). This ﬁ  nding was 
surprising since, in theory, use of mosquito precautions 
should reduce the risk for WNV infection. However, when 
asked about the types of mosquito precautions used, many 
participants reported methods that may be ineffective such 
as using candles or ﬁ  re as a deterrent or swatting at mosqui-
toes. Education regarding appropriate preventive methods 
would be valuable in this population.
In addition, we found that marijuana use predicted 
WNV infection, which is difﬁ  cult to explain. To our knowl-
edge, this is the ﬁ  rst report of marijuana use being a risk 
factor for WNV infection. Several explanations are possi-
ble, however: 1) this ﬁ  nding was due to chance, 2) persons 
using marijuana may spend more time outdoors between 
dusk and dawn when the Culex mosquito is most active, 3) 
the mosquito vector could be attracted to marijuana smoke, 
or 4) marijuana use could affect cognition, thereby prevent-
ing the user from interrupting a mosquito taking a blood 
meal. The relationship between marijuana use and WNV 
infection deserves further investigation.
Table 1. Participant demographics and WNV prevalence from the 2004 Houston Homeless Seroprevalence Study* 
WNV prevalence 
Demographic characteristics 
All participants,  
n = 397 (%)  No. (%)  95% CI 
Risk for WNV infection, 
OR (95% CI) 
Sex 
  Female  110 (28)  3 (2.7)  0.6–7.8 Reference
  Male  287 (72)  24 (8.4)  5.4–12.2 3.3 (0.96–11.0) 
Age, y 
  18–34  97 (24)  2 (2.1)  0.3–7.3 Reference
  35–49  204 (51)  17 (8.3)  4.9–13.0 4.3 (0.98–19.1) 
>50 95 (24)  8 (8.4)  3.7–15.9 4.4 (0.9–21.1) 
 Unknown  1  (0.3)  0 – –
Race
  White  120 (30)  8 (6.7)  2.9–12.7 Reference
  Black  233 (59)  18 (7.7)  4.6–11.9 1.2 (0.5–2.8) 
  Other/unknown  44 (11)  1 (2.3)  0.06–12.0 0.3 (0.04–2.7) 
Ethnicity 
  Hispanic  52 (13)  2 (3.9)  0.5–13.2 Reference
  Non-Hispanic  343 (86)  24 (7.0)  4.5–10.2 1.9 (0.4–8.2) 
  No response  2 (0.5)  1 (50.0)  1.3–98.7 –
*WNV, West Nile virus; OR, odds ratio; CI, confidence interval. 1502  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 10, October 2007
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For comparison, data on WNV prevalence in a non-
homeless population during the same time period and loca-
tion would be useful. After the 2003 transmission season, 
a study at the University of Texas Health Science Center at 
Houston found a seroprevalence of 4.7% among 274 stu-
dents, faculty, and staff (K. Murray, unpub. data).
This study provides important information on the mag-
nitude and risk factors for WNV infection among homeless 
persons. Combining education with distribution of effec-
tive mosquito prevention aids such as mosquito repellent 
may help reduce the risk for WNV infection and other mos-
quitoborne diseases in this high-risk population.
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Table 2. Self-reported social histories and prevalence of WNV infection from the 2004 Houston Homeless Seroprevalence Study* 
WNV prevalence 
Participant characteristics 
All participants, 
n = 397 (%)  No. (%)  95% CI 
Risk for WNV infection, 
OR (95% CI) 
Housing status† 
  Stable housing, 2002 and 2003  278 (70)  13 (4.7)  2.5–7.9 Reference
  Unstable housing, 2002 or 2003  69 (17)  7 (10.1)  4.2–19.8 2.3 (0.9–6.0) 
  Unstable housing, 2002 and 2003  45 (11)  6 (13.3)  5.1–26.8 3.1 (1.1–8.7)‡ 
  Unknown  5 (1)  1 (20.0)  0.5–71.6 –
Homelessness status 
  Does not consider himself or herself  
 homeless 
111 (28)  8 (7.2)  3.2–13.7 Reference
  Lives mostly on the streets  50 (13)  6 (12.0)  4.5–24.3 1.8 (0.6–5.4) 
  Lives in temporary shelter  125 (31)  10 (8.0)  3.9–14.2 1.1 (0.4–2.9) 
  Lives temporarily with friends/family  64 (16)  1 (1.6)  0.04–8.4 0.2 (0.02–1.7) 
  Other  47 (12)  2 (4.3)  0.5–14.5 0.6 (0.1–2.8) 
Length of time homeless 
  Does not consider himself or herself 
  homeless or homeless <1 mo 
171 (43)  10 (5.9)  2.8–10.5 Reference
  1 mo–1 y  153 (39)  5 (3.3)  1.1–7.5 0.5 (0.2–1.6) 
  >1 y  73 (18)  12 (16.4)  8.8–27.0 3.2 (1.3–7.7)‡ 
Time spent outdoors on average each day during summer and fall§ 
   6 h  150 (38)  3 (2.0)  0.4–5.7 Reference
  6–12 h  150 (38)  12 (8.0)  4.2–13.6 4.3 (1.2–15.4)¶ 
  >12 h  96 (24)  12 (12.5)  6.6–20.8 7.0 (1.9–25.5)‡ 
  Unknown  1 (0.3)  0 (0)  – –
Substance use# 
  Current tobacco use  273 (69)  20 (7.3) 4.5–11.1 1.3 (0.5–3.2) 
  >15 drinks containing alcohol/wk  70 (18)  3 (4.3)  0.9–12.0 0.6 (0.2–1.9) 
  Ever used street drugs  281 (71)  19 (6.8)  4.1–10.4 1.0 (0.4–2.3) 
  Ever used needles to inject street drugs  89 (22)  6 (6.7)  2.5–14.1 1.0 (0.4–2.5) 
  Current drug use (within past 6 mo)  108 (27)  11 (10.2)  5.2–17.5 1.9 (0.9–4.3) 
  Street drugs used in past 6 mo** 
  CNS stimulants (crack/cocaine/  
 amphetamines) 
84 (21)  5 (6.0)  2.0–13.3 0.8 (0.3–2.3) 
  Heroin/opiates   4 (1)  0 (0)  – –
  Marijuana   61 (15)  8 (13.1)  5.8–24.2 2.5 (1.0–6.0)¶ 
*WNV, West Nile virus; OR, odds ratio; CI, confidence interval; CNS, central nervous system. 
†p value for trend = 0.02. 
‡Significant at α = 0.01. 
§p value for trend = 0.002. 
¶Significant at α = 0.05.  
#Alcohol and current drug use will most likely be underestimated because shelters did not allow use of these substances.  
**Not mutually exclusive, hence univariate analysis compared specific drug use with no use of that drug.   Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 10, October 2007  1503 
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